Evidence map›Paper›PMID 17072976›Full record

ArticleWorld journal of gastroenterology2006

Identification of specific genes and pathways involved in NSAIDs-induced apoptosis of human colon cancer cells.

Richard-H Huang, Jianyuan Chai, Andrzej-S Tarnawski

Open access · hybridAbstract read
In one paragraph

Article in World journal of gastroenterology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.4field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Richard-H HuangDepartment of Medicine, Division of Gastroenterology, University of California Irvine and VA Long Beach Healthcare System, California, United States.
Jianyuan Chai
Andrzej-S Tarnawski
VA Long Beach Healthcare System · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo study whether indomethacin (IND), a nonselective cyclooxygenase (COX) inhibitor or NS-398 (NS), a COX-2-selective inhibitor, induces apoptosis in human colon cancer cells and which apoptosis-related genes and pathways are involved.

methodsHuman colon cancer Caco-2 cells were treated with either: placebo, IND (0.05-0.5 mmol/L) or NS (0.01-0.2 mmol/L) for 1, 5 and 18 h. We then studied: (1) Cell death by the TUNEL method, (2) mRNA expression of 96 apoptosis-related genes using DNA microarray, (3) expression of selected apoptosis related proteins by Western blotting.

resultsBoth IND and NS induced apoptosis in 30%-50% of Caco-2 cells in a dose dependent manner. IND (0.1 mmol/L for 1 h) significantly up-regulated pro-apoptotic genes in four families: (1) TNF receptor and ligand, (2) Caspase, (3) Bcl-2 and (4) Caspase recruiting domain. NS treatment up-regulated similar pro-apoptotic genes as IND. In addition, IND also down-regulated anti-apoptotic genes of the IAP family.

conclusion(1) Both non-selective and COX-2-selective NSAIDs induce apoptosis in colon cancer cells in a dose dependent manner. (2) Both NSAIDs induce apoptosis by activating two main apoptotic pathways: the death receptor pathway (involving TNF-R) and the mitochondrial pathway. (3) IND induces apoptosis by up-regulating pro-apoptotic genes and down-regulating anti-apoptotic genes, while NS only up-regulates pro-apoptotic genes. (4) Induction of apoptosis in colon cancer cells by NSAIDs may explain in part, their inhibitory action on colon cancer growth.

Indexed as

AdenocarcinomaAnti-Inflammatory Agents, Non-SteroidalApoptosisCaco-2 CellsCaspasesColonic NeoplasmsCyclooxygenase 2 InhibitorsCyclooxygenase InhibitorsDose-Response Relationship, DrugGene Expression Regulation, NeoplasticHumansIndomethacinNitrobenzenesOligonucleotide Array Sequence AnalysisProto-Oncogene Proteins c-bcl-2Receptors, Tumor Necrosis FactorAnti-Inflammatory Agents, Non-SteroidalCaspasesCyclooxygenase 2 InhibitorsCyclooxygenase InhibitorsIndomethacinN-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamideNitrobenzenesProto-Oncogene Proteins c-bcl-2Receptors, Tumor Necrosis FactorSulfonamides

Identifiers

PMID17072976
PMCPMC4100633
OpenAlexW209614719

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.